Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Corcept Therapeutics

Corcept Therapeutics
1998 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
CORT STOCK SYMBOL
$13.10 SHARE PRICE (As of Wednesday Closing)
Description

Corcept Therapeutics Inc is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects of cortisol.

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 149 Commonwealth Drive
  • Menlo Park, CA 94025
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Corcept Therapeutics’s full profile, request a free trial.

Corcept Therapeutics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$9.14 - $17.48 $1.5B $12.78 $0.76 990K 114M

Corcept Therapeutics Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 1,406,603 1,347,509 1,985,926 776,951
Revenue 285,422 251,247 159,201 81,321
EBITDA 103,171 89,732 52,961 10,266
Net Income 86,808 75,410 129,122 8,140
Total Assets 367,022 311,694 220,537 68,753
Total Debt 770 0 0 14,664
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Corcept Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Corcept Therapeutics‘s full profile, request access.

Request full access to PitchBook

Corcept Therapeutics Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cytokinetics Formerly VC-backed South San Francisco, CA 000 00000 00000000000 00000
000000000 00000000 Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
0000000 0000000000 Venture Capital-Backed San Diego, CA 0000 00000000000 0000
000000000 00000000 Corporation Pasadena, CA 000 00.000 0000
00000000 000000000 Formerly VC-backed Ann Arbor, MI 00 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

Corcept Therapeutics Executive Team (7)

Name Title Board
Seat
Contact
Info
Joseph Belanoff MD Chief Executive Officer & Founder
Charles Robb JD Chief Financial Officer
Hazel Hunt Ph.D Director, Research
Daniel Bradbury Independent Director

3 Former Executives

You’re viewing 4 of 7 executives. Get the full list »

Corcept Therapeutics Board Members (8)

Name Representing Role Since Contact
Info
Daniel Swisher Jr. Self Board Member 000 0000
David Mahoney Self Board Member 000 0000
George Baker Jr. Self Board Member 000 0000
James Wilson Self Chairman & Board Member 000 0000

4 Former Board Members

You’re viewing 4 of 8 board members. Get the full list »